MFN2 and Alzheimer disease: In AD cases, layer 5 exhibited increased Drp-1 (p = 0.0108) and Mfn-2 (p ≤ 0.0001) levels accompanied by decreased Opa-1 levels (p ≤ 0.0001) compared to aging cases (Figure 4D–F).